Abstract:Renal secretion plays an important role in drug excretion from the kidney. Two major transporters known to be highly involved in renal secretion are MATE1/2-K and OCT2, the former of which is highly related to drug-drug interactions. Among published in silico models for MATE inhibitors, a previous model obtained a ROC-AUC value of 0.78 using high throughput percentage inhibition data [J Med Chem. 2013;56(3): 781–795] which we aimed to improve upon here using a combined fingerprint and physics-based approach. To this end, we collected 225 publicly available compounds with pIC50 values against MATE1. Subsequently, on the one hand we performed a physics-based approach using an Alpha-Fold protein structure, from which we obtained MM-GB/SA scores for those compounds. On the other hand, we built Random Forest (RF) and Message Passing Neural Network (MPNN) models using Extended-Connectivity Fingerprints with radius 4 (ECFP4) and chemical structures as graphs, respectively, which also included MM-GB/SA scores as input variables. In a five-fold cross-validation with a separate test set we found that the best predictivity for the hold-out test was observed in the RF model (including ECFP4 and MM-GB/SA data) with an ROC-AUC of 0.833±0.036; while that of the MM-GB/SA regression model was 0.742. However, the MM-GB/SA model was able to extrapolate to novel chemical space better. Additionally, via Structural Interaction Fingerprint analysis, we identified interacting residues with inhibitor as identical for those with non-inhibitors, including substrates, such as Gln49, Trp274, Tyr277, Tyr299, Ile303, Tyr306. The similar binding modes are consistent with the observed similar IC50 values inhibitor when using different substrates experimentally, and practically this can release the experimental scientists from bothering of selecting substrates for MATE1. Hence, we were able to build a highly predictive classification models for MATE1 inhibitory activity with both ECFP4 and MM-GB/SA score as input features, which is fit-for-purpose for use in the drug discovery process.

Transfer inhibitory potency prediction to binary classification: A model only needs a small training set

Small dataset solves big problem: An outlier-insensitive binary classifier for inhibitory potency prediction

Predicting Protein-Ligand Interactions Based on Bow-Pharmacological Space and Bayesian Additive Regression Trees

A feature transferring workflow between data-poor compounds in various tasks

Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence

SAE-SV: A Stacked-AutoEncoder and Soft Voting Joint Approach Based on Small Dataset with High Dimensions for Inhibitory Potency Prediction

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Binding affinity prediction for binary drug-target interactions using semi-supervised transfer learning

Pred-binding: large-scale protein–ligand binding affinity prediction

Ligand Classifier of Adaptively Boosting Ensemble Decision Stumps (LiCABEDS) and its application on modeling ligand functionality for 5HT-subtype GPCR families

Prediction of Inhibitory Activity Against the MATE1 Transporter via Combined Fingerprint- and Physics-Based Machine Learning Models

A Hybrid Structure-Based Machine Learning Approach for Predicting Kinase Inhibition by Small Molecules

Discrimination vs. Generation: The Machine Learning Dichotomy for Dopaminergic Hit Discovery

In Silico Prediction of Inhibitors for Multiple Transporters via Machine Learning Methods

Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT

SMPLIP-Score: predicting ligand binding affinity from simple and interpretable on-the-fly interaction fingerprint pattern descriptors

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

Improving drug-target affinity prediction via feature fusion and knowledge distillation

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

Drug-target affinity prediction method based on consistent expression of heterogeneous data

Discrimination of Approved Drugs from Experimental Drugs by Learning Methods